AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...

COVID-19 vaccine would continue despite many European nations pausing vaccination to investigate serious side effects ...

AstraZeneca CEO Pascal Soriot discusses Q3 earnings and the pharma giant's relationship with the U.S. administration.

The pharmaceutical company posted a 14% on-year increase in third-quarter core earnings per share, while revenue rose to ...

New phase 3 data show meaningful improvement in antibody-negative myasthenia gravis, for which treatment options are limited ...

AstraZeneca beat expectations for third quarter earnings on Thursday with strong sales of its blockbuster cancer and ...

AstraZeneca ( AZN) posted stronger-than-expected Q3 results, fueled by continued strength in its oncology portfolio. The U.K.

The latest investor updates on stocks that are trending on Thursday.

Astrazeneca PLC (AZN) on Thursday reported third-quarter net income of $2.53 billion. On a per-share basis, the Cambridge, Britain-based company said it had net income of 81 cents. Earnings, adjusted ...

AstraZeneca reported its largest quarterly revenue ever, as soaring sales of cancer drugs helped the drugmaker beat ...

AstraZeneca beat third-quarter earnings expectations on Thursday, helped by strong sales of key cancer, heart and kidney ...

LONDON: British pharmaceutical giant AstraZeneca on Thursday said its net profit jumped 77 percent in the third quarter as ...